BioLinker raises $1.7M seed
Announced 6 October 2026
◆ The Round
BioLinker raised $1.7M in seed funding, announced on 6 October 2026, led by Axcell, with participation from FAPESP. The round is tracked live by Fusion42 as part of the Raise fund database and the Scout startup database.
◆ About BioLinker
Brazilian biotech startup that develops and manufactures recombinant proteins using synthetic biology and genetic engineering for research, diagnostics, and industrial applications. BioLinker is based in Brazil and currently at seed stage, operating in Biotech.
◆ Investors
LeadAxcell
ParticipationFAPESP
◆ Market context
This funding event is a citable node in Fusion42's market graph: it links BioLinker's Scout profile to the funds behind the round and to related Wire analysis, and is refreshed from public announcements as the round is confirmed or extended. It is the same live market data Arthur reasons over when benchmarking a founder's own raise against what is closing in the market right now.
◆ Explore the market
◆ FAQ
How much did BioLinker raise?
BioLinker raised $1.7M in its seed round, announced 2026-10-06.
Who invested in BioLinker's seed round?
The round was led by Axcell, with participation from FAPESP.
What does BioLinker do?
Brazilian biotech startup that develops and manufactures recombinant proteins using synthetic biology and genetic engineering for research, diagnostics, and industrial applications.
Verified 6 October 2026 · Sources: public filings